These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 16269383)
1. Changes in C-reactive protein predict insulin sensitivity in severely obese individuals after weight loss surgery. Gletsu N; Lin E; Khaitan L; Lynch SA; Ramshaw B; Raziano R; Torres WE; Ziegler TR; Papanicolaou DA; Smith CD J Gastrointest Surg; 2005 Nov; 9(8):1119-26; discussion 1127-8. PubMed ID: 16269383 [TBL] [Abstract][Full Text] [Related]
2. Increased plasma interleukin 6 concentrations and exaggerated adipose tissue interleukin 6 content in severely obese patients after operative trauma. Gletsu N; Lin E; Zhu JL; Khaitan L; Ramshaw BJ; Farmer PK; Ziegler TR; Papanicolaou DA; Smith CD Surgery; 2006 Jul; 140(1):50-7. PubMed ID: 16857442 [TBL] [Abstract][Full Text] [Related]
3. CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects. Holdstock C; Lind L; Engstrom BE; Ohrvall M; Sundbom M; Larsson A; Karlsson FA Int J Obes (Lond); 2005 Oct; 29(10):1275-80. PubMed ID: 16010285 [TBL] [Abstract][Full Text] [Related]
4. Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp. Lima MM; Pareja JC; Alegre SM; Geloneze SR; Kahn SE; Astiarraga BD; Chaim EA; Geloneze B J Clin Endocrinol Metab; 2010 Aug; 95(8):3871-5. PubMed ID: 20484482 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Bojsen-Møller KN Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541 [TBL] [Abstract][Full Text] [Related]
6. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients. Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Swarbrick MM; Stanhope KL; Austrheim-Smith IT; Van Loan MD; Ali MR; Wolfe BM; Havel PJ Diabetologia; 2008 Oct; 51(10):1901-11. PubMed ID: 18704364 [TBL] [Abstract][Full Text] [Related]
8. A multidimensional analysis of the longitudinal effects of roux en y gastric bypass on fatigue: An association with visceral obesity. Gletsu-Miller N; Shevni N; Manatunga A; Lin E; Musselman D Physiol Behav; 2019 Oct; 209():112612. PubMed ID: 31299372 [TBL] [Abstract][Full Text] [Related]
9. Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways. Montecucco F; Lenglet S; Quercioli A; Burger F; Thomas A; Lauer E; da Silva AR; Mach F; Vuilleumier N; Bobbioni-Harsch E; Golay A; Schindler TH; Pataky Z Thromb Haemost; 2015 Apr; 113(4):838-50. PubMed ID: 25413674 [TBL] [Abstract][Full Text] [Related]
10. Adipocyte fatty acid-binding protein as a determinant of insulin sensitivity in morbid-obese women. Simón I; Escoté X; Vilarrasa N; Gómez J; Fernández-Real JM; Megía A; Gutiérrez C; Gallart L; Masdevall C; Vendrell J Obesity (Silver Spring); 2009 Jun; 17(6):1124-8. PubMed ID: 19197257 [TBL] [Abstract][Full Text] [Related]
11. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Wickremesekera K; Miller G; Naotunne TD; Knowles G; Stubbs RS Obes Surg; 2005 Apr; 15(4):474-81. PubMed ID: 15946424 [TBL] [Abstract][Full Text] [Related]
12. Visceral fat resection in humans: effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers. Lima MM; Pareja JC; Alegre SM; Geloneze SR; Kahn SE; Astiarraga BD; Chaim ÉA; Baracat J; Geloneze B Obesity (Silver Spring); 2013 Mar; 21(3):E182-9. PubMed ID: 23404948 [TBL] [Abstract][Full Text] [Related]
13. The effects of roux en y gastric bypass surgery on neurobehavioral symptom domains associated with severe obesity. Musselman D; Shenvi N; Manatunga A; Miller AH; Lin E; Gletsu-Miller N Physiol Behav; 2019 May; 204():86-92. PubMed ID: 30763595 [TBL] [Abstract][Full Text] [Related]
14. Differential effect of weight loss on insulin resistance in surgically treated obese patients. Muscelli E; Mingrone G; Camastra S; Manco M; Pereira JA; Pareja JC; Ferrannini E Am J Med; 2005 Jan; 118(1):51-7. PubMed ID: 15639210 [TBL] [Abstract][Full Text] [Related]
15. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Kopp HP; Kopp CW; Festa A; Krzyzanowska K; Kriwanek S; Minar E; Roka R; Schernthaner G Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1042-7. PubMed ID: 12714437 [TBL] [Abstract][Full Text] [Related]
16. Improved Insulin Sensitivity 3 Months After RYGB Surgery Is Associated With Increased Subcutaneous Adipose Tissue AMPK Activity and Decreased Oxidative Stress. Xu XJ; Apovian C; Hess D; Carmine B; Saha A; Ruderman N Diabetes; 2015 Sep; 64(9):3155-9. PubMed ID: 26001396 [TBL] [Abstract][Full Text] [Related]
17. Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery. Swarbrick MM; Austrheim-Smith IT; Stanhope KL; Van Loan MD; Ali MR; Wolfe BM; Havel PJ Diabetologia; 2006 Nov; 49(11):2552-8. PubMed ID: 17019599 [TBL] [Abstract][Full Text] [Related]
18. Gastric bypass-induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers. Barazzoni R; Palmisano S; Gortan Cappellari G; Giuricin M; Moretti E; Vinci P; Semolic A; Guarnieri G; Zanetti M; Manzini Nd Surg Obes Relat Dis; 2016 Jan; 12(1):23-32. PubMed ID: 26277450 [TBL] [Abstract][Full Text] [Related]
19. Effect of Roux-en-Y Gastric Bypass on the NLRP3 Inflammasome in Adipose Tissue from Obese Rats. Mocanu AO; Mulya A; Huang H; Dan O; Shimizu H; Batayyah E; Brethauer SA; Dinischiotu A; Kirwan JP PLoS One; 2015; 10(10):e0139764. PubMed ID: 26437377 [TBL] [Abstract][Full Text] [Related]
20. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH. Anty R; Bekri S; Luciani N; Saint-Paul MC; Dahman M; Iannelli A; Amor IB; Staccini-Myx A; Huet PM; Gugenheim J; Sadoul JL; Le Marchand-Brustel Y; Tran A; Gual P Am J Gastroenterol; 2006 Aug; 101(8):1824-33. PubMed ID: 16790033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]